$244 Million is the total value of Tri Locum Partners LP's 51 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 124.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARGX | Buy | ARGENX SEsponsored adr | $31,347,000 | +177.1% | 82,735 | +130.6% | 12.84% | +190.5% |
| LLY | Buy | LILLY ELI & CO | $22,588,000 | +89.6% | 69,667 | +67.4% | 9.25% | +98.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $17,369,000 | +38.2% | 182,654 | +71.0% | 7.11% | +44.8% |
| Buy | STEVANATO GROUP S P A | $14,063,000 | +67.7% | 889,496 | +113.3% | 5.76% | +75.7% | |
| CCXI | Buy | CHEMOCENTRYX INC | $13,518,000 | +82.0% | 545,532 | +84.1% | 5.54% | +90.7% |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $11,757,000 | +41.2% | 914,194 | +85.3% | 4.81% | +48.0% |
| CTLT | New | CATALENT INC | $11,613,000 | – | 108,241 | +100.0% | 4.76% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $10,482,000 | +50.9% | 1,134,408 | +12.4% | 4.29% | +58.2% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $9,977,000 | +33.4% | 324,869 | +40.3% | 4.08% | +39.8% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $8,970,000 | +59.4% | 317,758 | +113.2% | 3.67% | +67.0% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $8,949,000 | -56.0% | 57,363 | -56.1% | 3.66% | -53.9% |
| GH | New | GUARDANT HEALTH INC | $7,758,000 | – | 192,308 | +100.0% | 3.18% | – |
| TCDA | Buy | TRICIDA INC | $7,077,000 | +100.5% | 731,142 | +70.3% | 2.90% | +110.2% |
| ALT | New | ALTIMMUNE INC | $6,723,000 | – | 574,646 | +100.0% | 2.75% | – |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $6,369,000 | – | 111,572 | +100.0% | 2.61% | – |
| BNTX | Buy | BIONTECH SEsponsored ads | $5,914,000 | +12.1% | 39,663 | +28.3% | 2.42% | +17.6% |
| INSP | New | INSPIRE MED SYS INC | $5,792,000 | – | 31,705 | +100.0% | 2.37% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $5,484,000 | -60.6% | 68,750 | -48.0% | 2.25% | -58.7% |
| XENE | New | XENON PHARMACEUTICALS INC | $5,062,000 | – | 166,399 | +100.0% | 2.07% | – |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $4,171,000 | -65.7% | 504,342 | -31.0% | 1.71% | -64.0% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $3,926,000 | – | 162,014 | +100.0% | 1.61% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $3,563,000 | -72.7% | 132,148 | -65.5% | 1.46% | -71.4% |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $3,102,000 | – | 272,123 | +100.0% | 1.27% | – |
| RVMD | Sell | REVOLUTION MEDICINES INC | $2,893,000 | -33.5% | 148,453 | -12.9% | 1.18% | -30.2% |
| CHRS | New | COHERUS BIOSCIENCES INC | $2,726,000 | – | 376,486 | +100.0% | 1.12% | – |
| ACET | Sell | ADICET BIO INC | $2,684,000 | -74.3% | 183,857 | -64.9% | 1.10% | -73.1% |
| EOLS | New | EVOLUS INC | $2,526,000 | – | 217,767 | +100.0% | 1.03% | – |
| New | SCIENCE 37 HOLDINGS INC | $2,083,000 | – | 1,036,194 | +100.0% | 0.85% | – | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $1,677,000 | -44.2% | 1,738,300 | +1.2% | 0.69% | -41.5% |
| New | AMYLYX PHARMACEUTICALS INC | $1,550,000 | – | 80,459 | +100.0% | 0.64% | – | |
| PTGX | New | PROTAGONIST THERAPEUTICS INCcall | $1,226,000 | – | 155,000 | +100.0% | 0.50% | – |
| MMM | New | 3M CO | $210,000 | – | 1,619 | +100.0% | 0.09% | – |
| FEMY | Sell | FEMASYS INC | $202,000 | +1.5% | 83,831 | -4.7% | 0.08% | +6.4% |
| NLY | Buy | ANNALY CAPITAL MANAGEMENT IN | $104,000 | -8.0% | 17,666 | +10.0% | 0.04% | -2.3% |
| RIG | New | TRANSOCEAN LTD | $66,000 | – | 19,683 | +100.0% | 0.03% | – |
| ALLK | New | ALLAKOS INC | $63,000 | – | 20,029 | +100.0% | 0.03% | – |
| NG | New | NOVAGOLD RES INC | $55,000 | – | 11,433 | +100.0% | 0.02% | – |
| STTK | New | SHATTUCK LABS INC | $54,000 | – | 13,230 | +100.0% | 0.02% | – |
| AVPT | New | AVEPOINT INC | $53,000 | – | 12,140 | +100.0% | 0.02% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $51,000 | – | 13,402 | +100.0% | 0.02% | – |
| CVM | New | CEL-SCI CORP | $50,000 | – | 11,206 | +100.0% | 0.02% | – |
| ADV | New | ADVANTAGE SOLUTIONS INC | $46,000 | – | 12,156 | +100.0% | 0.02% | – |
| LEV | New | THE LION ELECTRIC COMPANY | $44,000 | – | 10,466 | +100.0% | 0.02% | – |
| SKIL | New | SKILLSOFT CORPcl a | $38,000 | – | 10,891 | +100.0% | 0.02% | – |
| UP | New | WHEELS UP EXPERIENCE INC | $39,000 | – | 19,892 | +100.0% | 0.02% | – |
| ME | New | 23ANDME HOLDING CO CLASS A | $36,000 | – | 14,367 | +100.0% | 0.02% | – |
| GATO | New | GATOS SILVER INC | $35,000 | – | 12,062 | +100.0% | 0.01% | – |
| AVAH | Buy | AVEANNA HEALTHCARE HLDGS INC | $34,000 | -8.1% | 15,151 | +39.7% | 0.01% | 0.0% |
| New | MARKFORGED HOLDING CORPORATI | $33,000 | – | 17,585 | +100.0% | 0.01% | – | |
| ALGS | New | ALIGOS THERAPEUTICS INC | $35,000 | – | 29,302 | +100.0% | 0.01% | – |
| New | DOMA HOLDINGS INC | $23,000 | – | 21,974 | +100.0% | 0.01% | – | |
| SKLZ | Exit | SKILLZ INC | $0 | – | -11,275 | -100.0% | -0.01% | – |
| INSG | Exit | INSEEGO CORP | $0 | – | -10,831 | -100.0% | -0.02% | – |
| UWMC | Exit | UWM HOLDINGS CORPORATION | $0 | – | -10,330 | -100.0% | -0.02% | – |
| CASA | Exit | CASA SYS INC | $0 | – | -11,351 | -100.0% | -0.02% | – |
| GNW | Exit | GENWORTH FINL INC | $0 | – | -15,436 | -100.0% | -0.02% | – |
| SPNT | Exit | SIRIUSPOINT LTD | $0 | – | -11,488 | -100.0% | -0.03% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,206,897 | -100.0% | -0.82% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -51,750 | -100.0% | -2.40% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -1,447,445 | -100.0% | -2.51% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -190,345 | -100.0% | -2.88% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -329,068 | -100.0% | -2.91% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -504,371 | -100.0% | -3.32% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -122,817 | -100.0% | -3.50% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -406,733 | -100.0% | -3.54% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -21,477 | -100.0% | -5.86% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -769,250 | -100.0% | -7.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.